Lancovutide (Moli1901) Inhalation Solution

Lancovutide · AOP Orphan Pharmaceuticals AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lancovutide (Moli1901) Inhalation Solution, covering 2009-08-27 to 2009-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Lancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic Fibrosis [Phase 2]